nodes	percent_of_prediction	percent_of_DWPC	metapath
Fondaparinux sodium—Vertigo—Triamcinolone—psoriatic arthritis	0.00165	0.00165	CcSEcCtD
Fondaparinux sodium—Syncope—Triamcinolone—psoriatic arthritis	0.00164	0.00164	CcSEcCtD
Fondaparinux sodium—Vertigo—Methylprednisolone—psoriatic arthritis	0.00164	0.00164	CcSEcCtD
Fondaparinux sodium—Syncope—Methylprednisolone—psoriatic arthritis	0.00164	0.00164	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Fondaparinux sodium—Oedema—Prednisolone—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Fondaparinux sodium—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Fondaparinux sodium—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Fondaparinux sodium—Shock—Prednisolone—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Fondaparinux sodium—Cough—Triamcinolone—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Fondaparinux sodium—Convulsion—Triamcinolone—psoriatic arthritis	0.00159	0.00159	CcSEcCtD
Fondaparinux sodium—Tachycardia—Prednisolone—psoriatic arthritis	0.00159	0.00159	CcSEcCtD
Fondaparinux sodium—Convulsion—Methylprednisolone—psoriatic arthritis	0.00158	0.00158	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.00157	0.00157	CcSEcCtD
Fondaparinux sodium—Anxiety—Methylprednisolone—psoriatic arthritis	0.00155	0.00155	CcSEcCtD
Fondaparinux sodium—Infestation—Methotrexate—psoriatic arthritis	0.00155	0.00155	CcSEcCtD
Fondaparinux sodium—Infestation NOS—Methotrexate—psoriatic arthritis	0.00155	0.00155	CcSEcCtD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.00155	0.00155	CcSEcCtD
Fondaparinux sodium—Flushing—Prednisone—psoriatic arthritis	0.00154	0.00154	CcSEcCtD
Fondaparinux sodium—Renal failure—Methotrexate—psoriatic arthritis	0.00152	0.00152	CcSEcCtD
Fondaparinux sodium—Angioedema—Betamethasone—psoriatic arthritis	0.00152	0.00152	CcSEcCtD
Fondaparinux sodium—Angioedema—Dexamethasone—psoriatic arthritis	0.00152	0.00152	CcSEcCtD
Fondaparinux sodium—Angiopathy—Prednisone—psoriatic arthritis	0.00151	0.00151	CcSEcCtD
Fondaparinux sodium—Confusional state—Methylprednisolone—psoriatic arthritis	0.00151	0.00151	CcSEcCtD
Fondaparinux sodium—Immune system disorder—Prednisone—psoriatic arthritis	0.0015	0.0015	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.0015	0.0015	CcSEcCtD
Fondaparinux sodium—Oedema—Triamcinolone—psoriatic arthritis	0.0015	0.0015	CcSEcCtD
Fondaparinux sodium—Vertigo—Dexamethasone—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Fondaparinux sodium—Vertigo—Betamethasone—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Fondaparinux sodium—Syncope—Betamethasone—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Fondaparinux sodium—Syncope—Dexamethasone—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Fondaparinux sodium—Arrhythmia—Prednisone—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Fondaparinux sodium—Infection—Triamcinolone—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Fondaparinux sodium—Infection—Methylprednisolone—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Fondaparinux sodium—Haematuria—Methotrexate—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Fondaparinux sodium—Shock—Triamcinolone—psoriatic arthritis	0.00147	0.00147	CcSEcCtD
Fondaparinux sodium—Insomnia—Prednisolone—psoriatic arthritis	0.00147	0.00147	CcSEcCtD
Fondaparinux sodium—Shock—Methylprednisolone—psoriatic arthritis	0.00147	0.00147	CcSEcCtD
Fondaparinux sodium—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.00147	0.00147	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.00146	0.00146	CcSEcCtD
Fondaparinux sodium—Loss of consciousness—Betamethasone—psoriatic arthritis	0.00146	0.00146	CcSEcCtD
Fondaparinux sodium—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.00146	0.00146	CcSEcCtD
Fondaparinux sodium—Epistaxis—Methotrexate—psoriatic arthritis	0.00146	0.00146	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Prednisolone—psoriatic arthritis	0.00146	0.00146	CcSEcCtD
Fondaparinux sodium—Tachycardia—Triamcinolone—psoriatic arthritis	0.00146	0.00146	CcSEcCtD
Fondaparinux sodium—Tachycardia—Methylprednisolone—psoriatic arthritis	0.00146	0.00146	CcSEcCtD
Fondaparinux sodium—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Fondaparinux sodium—Malnutrition—Prednisone—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Fondaparinux sodium—Convulsion—Betamethasone—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Fondaparinux sodium—Convulsion—Dexamethasone—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Fondaparinux sodium—Anxiety—Dexamethasone—psoriatic arthritis	0.00141	0.00141	CcSEcCtD
Fondaparinux sodium—Anxiety—Betamethasone—psoriatic arthritis	0.00141	0.00141	CcSEcCtD
Fondaparinux sodium—Haemoglobin—Methotrexate—psoriatic arthritis	0.0014	0.0014	CcSEcCtD
Fondaparinux sodium—Hypotension—Methylprednisolone—psoriatic arthritis	0.00139	0.00139	CcSEcCtD
Fondaparinux sodium—Pain—Prednisolone—psoriatic arthritis	0.00139	0.00139	CcSEcCtD
Fondaparinux sodium—Haemorrhage—Methotrexate—psoriatic arthritis	0.00139	0.00139	CcSEcCtD
Fondaparinux sodium—Vision blurred—Prednisone—psoriatic arthritis	0.00137	0.00137	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.00136	0.00136	CcSEcCtD
Fondaparinux sodium—Oedema—Betamethasone—psoriatic arthritis	0.00136	0.00136	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.00136	0.00136	CcSEcCtD
Fondaparinux sodium—Oedema—Dexamethasone—psoriatic arthritis	0.00136	0.00136	CcSEcCtD
Fondaparinux sodium—Insomnia—Triamcinolone—psoriatic arthritis	0.00135	0.00135	CcSEcCtD
Fondaparinux sodium—Insomnia—Methylprednisolone—psoriatic arthritis	0.00135	0.00135	CcSEcCtD
Fondaparinux sodium—Infection—Dexamethasone—psoriatic arthritis	0.00135	0.00135	CcSEcCtD
Fondaparinux sodium—Infection—Betamethasone—psoriatic arthritis	0.00135	0.00135	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Triamcinolone—psoriatic arthritis	0.00134	0.00134	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00134	0.00134	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.00134	0.00134	CcSEcCtD
Fondaparinux sodium—Anaemia—Prednisone—psoriatic arthritis	0.00134	0.00134	CcSEcCtD
Fondaparinux sodium—Shock—Dexamethasone—psoriatic arthritis	0.00134	0.00134	CcSEcCtD
Fondaparinux sodium—Shock—Betamethasone—psoriatic arthritis	0.00134	0.00134	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00133	0.00133	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00133	0.00133	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00133	0.00133	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.00133	0.00133	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.00133	0.00133	CcSEcCtD
Fondaparinux sodium—Tachycardia—Dexamethasone—psoriatic arthritis	0.00132	0.00132	CcSEcCtD
Fondaparinux sodium—Tachycardia—Betamethasone—psoriatic arthritis	0.00132	0.00132	CcSEcCtD
Fondaparinux sodium—Angioedema—Prednisone—psoriatic arthritis	0.00132	0.00132	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Triamcinolone—psoriatic arthritis	0.00132	0.00132	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.00131	0.00131	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.00131	0.00131	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.00131	0.00131	CcSEcCtD
Fondaparinux sodium—Vertigo—Prednisone—psoriatic arthritis	0.0013	0.0013	CcSEcCtD
Fondaparinux sodium—Syncope—Prednisone—psoriatic arthritis	0.0013	0.0013	CcSEcCtD
Fondaparinux sodium—Anorexia—Betamethasone—psoriatic arthritis	0.00129	0.00129	CcSEcCtD
Fondaparinux sodium—Anorexia—Dexamethasone—psoriatic arthritis	0.00129	0.00129	CcSEcCtD
Fondaparinux sodium—Urticaria—Prednisolone—psoriatic arthritis	0.00129	0.00129	CcSEcCtD
Fondaparinux sodium—Fatigue—Triamcinolone—psoriatic arthritis	0.00129	0.00129	CcSEcCtD
Fondaparinux sodium—Fatigue—Methylprednisolone—psoriatic arthritis	0.00129	0.00129	CcSEcCtD
Fondaparinux sodium—Pain—Triamcinolone—psoriatic arthritis	0.00128	0.00128	CcSEcCtD
Fondaparinux sodium—Loss of consciousness—Prednisone—psoriatic arthritis	0.00127	0.00127	CcSEcCtD
Fondaparinux sodium—Hypotension—Betamethasone—psoriatic arthritis	0.00127	0.00127	CcSEcCtD
Fondaparinux sodium—Hypotension—Dexamethasone—psoriatic arthritis	0.00127	0.00127	CcSEcCtD
Fondaparinux sodium—Angiopathy—Methotrexate—psoriatic arthritis	0.00126	0.00126	CcSEcCtD
Fondaparinux sodium—Immune system disorder—Methotrexate—psoriatic arthritis	0.00126	0.00126	CcSEcCtD
Fondaparinux sodium—Convulsion—Prednisone—psoriatic arthritis	0.00126	0.00126	CcSEcCtD
Fondaparinux sodium—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.00123	0.00123	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.00123	0.00123	CcSEcCtD
Fondaparinux sodium—Anxiety—Prednisone—psoriatic arthritis	0.00123	0.00123	CcSEcCtD
Fondaparinux sodium—Insomnia—Betamethasone—psoriatic arthritis	0.00123	0.00123	CcSEcCtD
Fondaparinux sodium—Insomnia—Dexamethasone—psoriatic arthritis	0.00123	0.00123	CcSEcCtD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Betamethasone—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Dexamethasone—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Fondaparinux sodium—Malnutrition—Methotrexate—psoriatic arthritis	0.00121	0.00121	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Prednisolone—psoriatic arthritis	0.0012	0.0012	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Dexamethasone—psoriatic arthritis	0.00119	0.00119	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Betamethasone—psoriatic arthritis	0.00119	0.00119	CcSEcCtD
Fondaparinux sodium—Urticaria—Triamcinolone—psoriatic arthritis	0.00119	0.00119	CcSEcCtD
Fondaparinux sodium—Urticaria—Methylprednisolone—psoriatic arthritis	0.00119	0.00119	CcSEcCtD
Fondaparinux sodium—Dysgeusia—Methotrexate—psoriatic arthritis	0.00119	0.00119	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Triamcinolone—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Prednisone—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Fondaparinux sodium—Oedema—Prednisone—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Dexamethasone—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Betamethasone—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Fondaparinux sodium—Infection—Prednisone—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Fondaparinux sodium—Back pain—Methotrexate—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Fondaparinux sodium—Fatigue—Dexamethasone—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Fondaparinux sodium—Fatigue—Betamethasone—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Fondaparinux sodium—Shock—Prednisone—psoriatic arthritis	0.00116	0.00116	CcSEcCtD
Fondaparinux sodium—Pain—Dexamethasone—psoriatic arthritis	0.00116	0.00116	CcSEcCtD
Fondaparinux sodium—Pain—Betamethasone—psoriatic arthritis	0.00116	0.00116	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Prednisone—psoriatic arthritis	0.00116	0.00116	CcSEcCtD
Fondaparinux sodium—Tachycardia—Prednisone—psoriatic arthritis	0.00115	0.00115	CcSEcCtD
Fondaparinux sodium—Skin disorder—Prednisone—psoriatic arthritis	0.00115	0.00115	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Prednisone—psoriatic arthritis	0.00114	0.00114	CcSEcCtD
Fondaparinux sodium—Vision blurred—Methotrexate—psoriatic arthritis	0.00114	0.00114	CcSEcCtD
Fondaparinux sodium—Anorexia—Prednisone—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Fondaparinux sodium—Anaemia—Methotrexate—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.00111	0.00111	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.00111	0.00111	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.0011	0.0011	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.0011	0.0011	CcSEcCtD
Fondaparinux sodium—Vertigo—Methotrexate—psoriatic arthritis	0.00109	0.00109	CcSEcCtD
Fondaparinux sodium—Urticaria—Dexamethasone—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Fondaparinux sodium—Urticaria—Betamethasone—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Fondaparinux sodium—Dizziness—Prednisolone—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Fondaparinux sodium—Asthenia—Triamcinolone—psoriatic arthritis	0.00107	0.00107	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Dexamethasone—psoriatic arthritis	0.00107	0.00107	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Betamethasone—psoriatic arthritis	0.00107	0.00107	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Betamethasone—psoriatic arthritis	0.00107	0.00107	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Dexamethasone—psoriatic arthritis	0.00107	0.00107	CcSEcCtD
Fondaparinux sodium—Asthenia—Methylprednisolone—psoriatic arthritis	0.00107	0.00107	CcSEcCtD
Fondaparinux sodium—Insomnia—Prednisone—psoriatic arthritis	0.00107	0.00107	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Prednisone—psoriatic arthritis	0.00106	0.00106	CcSEcCtD
Fondaparinux sodium—Pruritus—Triamcinolone—psoriatic arthritis	0.00106	0.00106	CcSEcCtD
Fondaparinux sodium—Cough—Methotrexate—psoriatic arthritis	0.00106	0.00106	CcSEcCtD
Fondaparinux sodium—Pruritus—Methylprednisolone—psoriatic arthritis	0.00106	0.00106	CcSEcCtD
Fondaparinux sodium—Convulsion—Methotrexate—psoriatic arthritis	0.00105	0.00105	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Prednisone—psoriatic arthritis	0.00104	0.00104	CcSEcCtD
Fondaparinux sodium—Chest pain—Methotrexate—psoriatic arthritis	0.00103	0.00103	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Prednisone—psoriatic arthritis	0.00103	0.00103	CcSEcCtD
Fondaparinux sodium—Rash—Prednisolone—psoriatic arthritis	0.00103	0.00103	CcSEcCtD
Fondaparinux sodium—Dermatitis—Prednisolone—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
Fondaparinux sodium—Fatigue—Prednisone—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
Fondaparinux sodium—Headache—Prednisolone—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
Fondaparinux sodium—Constipation—Prednisone—psoriatic arthritis	0.00101	0.00101	CcSEcCtD
Fondaparinux sodium—Confusional state—Methotrexate—psoriatic arthritis	0.000996	0.000996	CcSEcCtD
Fondaparinux sodium—Dizziness—Triamcinolone—psoriatic arthritis	0.000989	0.000989	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000988	0.000988	CcSEcCtD
Fondaparinux sodium—Dizziness—Methylprednisolone—psoriatic arthritis	0.000987	0.000987	CcSEcCtD
Fondaparinux sodium—Infection—Methotrexate—psoriatic arthritis	0.000982	0.000982	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Prednisone—psoriatic arthritis	0.000974	0.000974	CcSEcCtD
Fondaparinux sodium—Asthenia—Betamethasone—psoriatic arthritis	0.000974	0.000974	CcSEcCtD
Fondaparinux sodium—Asthenia—Dexamethasone—psoriatic arthritis	0.000974	0.000974	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000969	0.000969	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000967	0.000967	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000967	0.000967	CcSEcCtD
Fondaparinux sodium—Nausea—Prednisolone—psoriatic arthritis	0.000966	0.000966	CcSEcCtD
Fondaparinux sodium—Pruritus—Dexamethasone—psoriatic arthritis	0.00096	0.00096	CcSEcCtD
Fondaparinux sodium—Pruritus—Betamethasone—psoriatic arthritis	0.00096	0.00096	CcSEcCtD
Fondaparinux sodium—Skin disorder—Methotrexate—psoriatic arthritis	0.00096	0.00096	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000955	0.000955	CcSEcCtD
Fondaparinux sodium—Vomiting—Triamcinolone—psoriatic arthritis	0.000951	0.000951	CcSEcCtD
Fondaparinux sodium—Vomiting—Methylprednisolone—psoriatic arthritis	0.000949	0.000949	CcSEcCtD
Fondaparinux sodium—Rash—Triamcinolone—psoriatic arthritis	0.000943	0.000943	CcSEcCtD
Fondaparinux sodium—Dermatitis—Triamcinolone—psoriatic arthritis	0.000942	0.000942	CcSEcCtD
Fondaparinux sodium—Anorexia—Methotrexate—psoriatic arthritis	0.000942	0.000942	CcSEcCtD
Fondaparinux sodium—Rash—Methylprednisolone—psoriatic arthritis	0.000941	0.000941	CcSEcCtD
Fondaparinux sodium—Dermatitis—Methylprednisolone—psoriatic arthritis	0.00094	0.00094	CcSEcCtD
Fondaparinux sodium—Urticaria—Prednisone—psoriatic arthritis	0.000939	0.000939	CcSEcCtD
Fondaparinux sodium—Headache—Triamcinolone—psoriatic arthritis	0.000937	0.000937	CcSEcCtD
Fondaparinux sodium—Headache—Methylprednisolone—psoriatic arthritis	0.000935	0.000935	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Prednisone—psoriatic arthritis	0.000935	0.000935	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Prednisone—psoriatic arthritis	0.000935	0.000935	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000929	0.000929	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Betamethasone—psoriatic arthritis	0.000929	0.000929	CcSEcCtD
Fondaparinux sodium—Hypotension—Methotrexate—psoriatic arthritis	0.000923	0.000923	CcSEcCtD
Fondaparinux sodium—Dizziness—Betamethasone—psoriatic arthritis	0.000898	0.000898	CcSEcCtD
Fondaparinux sodium—Dizziness—Dexamethasone—psoriatic arthritis	0.000898	0.000898	CcSEcCtD
Fondaparinux sodium—Insomnia—Methotrexate—psoriatic arthritis	0.000894	0.000894	CcSEcCtD
Fondaparinux sodium—Nausea—Triamcinolone—psoriatic arthritis	0.000889	0.000889	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Methotrexate—psoriatic arthritis	0.000887	0.000887	CcSEcCtD
Fondaparinux sodium—Nausea—Methylprednisolone—psoriatic arthritis	0.000887	0.000887	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Methotrexate—psoriatic arthritis	0.000881	0.000881	CcSEcCtD
Fondaparinux sodium—Somnolence—Methotrexate—psoriatic arthritis	0.000878	0.000878	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Prednisone—psoriatic arthritis	0.000871	0.000871	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Methotrexate—psoriatic arthritis	0.00087	0.00087	CcSEcCtD
Fondaparinux sodium—Vomiting—Dexamethasone—psoriatic arthritis	0.000863	0.000863	CcSEcCtD
Fondaparinux sodium—Vomiting—Betamethasone—psoriatic arthritis	0.000863	0.000863	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Methotrexate—psoriatic arthritis	0.000859	0.000859	CcSEcCtD
Fondaparinux sodium—Rash—Dexamethasone—psoriatic arthritis	0.000856	0.000856	CcSEcCtD
Fondaparinux sodium—Rash—Betamethasone—psoriatic arthritis	0.000856	0.000856	CcSEcCtD
Fondaparinux sodium—Dermatitis—Betamethasone—psoriatic arthritis	0.000855	0.000855	CcSEcCtD
Fondaparinux sodium—Dermatitis—Dexamethasone—psoriatic arthritis	0.000855	0.000855	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000853	0.000853	CcSEcCtD
Fondaparinux sodium—Fatigue—Methotrexate—psoriatic arthritis	0.000852	0.000852	CcSEcCtD
Fondaparinux sodium—Headache—Betamethasone—psoriatic arthritis	0.00085	0.00085	CcSEcCtD
Fondaparinux sodium—Headache—Dexamethasone—psoriatic arthritis	0.00085	0.00085	CcSEcCtD
Fondaparinux sodium—Asthenia—Prednisone—psoriatic arthritis	0.000848	0.000848	CcSEcCtD
Fondaparinux sodium—Pain—Methotrexate—psoriatic arthritis	0.000845	0.000845	CcSEcCtD
Fondaparinux sodium—Pruritus—Prednisone—psoriatic arthritis	0.000836	0.000836	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000814	0.000814	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Prednisone—psoriatic arthritis	0.000809	0.000809	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000808	0.000808	CcSEcCtD
Fondaparinux sodium—Nausea—Dexamethasone—psoriatic arthritis	0.000806	0.000806	CcSEcCtD
Fondaparinux sodium—Nausea—Betamethasone—psoriatic arthritis	0.000806	0.000806	CcSEcCtD
Fondaparinux sodium—Urticaria—Methotrexate—psoriatic arthritis	0.000785	0.000785	CcSEcCtD
Fondaparinux sodium—Dizziness—Prednisone—psoriatic arthritis	0.000782	0.000782	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Methotrexate—psoriatic arthritis	0.000781	0.000781	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Methotrexate—psoriatic arthritis	0.000781	0.000781	CcSEcCtD
Fondaparinux sodium—Vomiting—Prednisone—psoriatic arthritis	0.000752	0.000752	CcSEcCtD
Fondaparinux sodium—Rash—Prednisone—psoriatic arthritis	0.000745	0.000745	CcSEcCtD
Fondaparinux sodium—Dermatitis—Prednisone—psoriatic arthritis	0.000745	0.000745	CcSEcCtD
Fondaparinux sodium—Headache—Prednisone—psoriatic arthritis	0.000741	0.000741	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000728	0.000728	CcSEcCtD
Fondaparinux sodium—Asthenia—Methotrexate—psoriatic arthritis	0.000709	0.000709	CcSEcCtD
Fondaparinux sodium—Nausea—Prednisone—psoriatic arthritis	0.000702	0.000702	CcSEcCtD
Fondaparinux sodium—Pruritus—Methotrexate—psoriatic arthritis	0.000699	0.000699	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Methotrexate—psoriatic arthritis	0.000676	0.000676	CcSEcCtD
Fondaparinux sodium—Dizziness—Methotrexate—psoriatic arthritis	0.000653	0.000653	CcSEcCtD
Fondaparinux sodium—Vomiting—Methotrexate—psoriatic arthritis	0.000628	0.000628	CcSEcCtD
Fondaparinux sodium—Rash—Methotrexate—psoriatic arthritis	0.000623	0.000623	CcSEcCtD
Fondaparinux sodium—Dermatitis—Methotrexate—psoriatic arthritis	0.000622	0.000622	CcSEcCtD
Fondaparinux sodium—Headache—Methotrexate—psoriatic arthritis	0.000619	0.000619	CcSEcCtD
Fondaparinux sodium—Nausea—Methotrexate—psoriatic arthritis	0.000587	0.000587	CcSEcCtD
